In vitro method to determine whether a drug candidate active against a target protein is active against a variant of said protein

Details for Australian Patent Application No. 2009224605 (hide)

Owner Vivalis

Inventors Valarche, Isabelle; Lahmar, Medhi; Mehtali, Majid

Agent Davies Collison Cave

Pub. Number AU-A-2009224605

PCT Pub. Number WO2009/112592

Priority 08300146.1 14.03.08 EP

Filing date 16 March 2009

Wipo publication date 17 September 2009

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/576 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for hepatitis

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

30 September 2010 PCT application entered the National Phase

  PCT publication WO2009/112592 Priority application(s): WO2009/112592

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009224613-Novel uses of sodium 4-phenylbutyrate (4 PBA) and the pharmaceutically acceptable salts thereof

2009224600-Variation of recombinant expression titres by optimising bacterial ribosome binding sites